JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB190875

Anti-ATP5C1 antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Goat Polyclonal ATP5C1 antibody. Suitable for WB and reacts with Rat samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human ATP5F1C aa 1-50.

View Alternative Names

ATP5C, ATP5C1, ATP5CL1, ATP5F1C, ATP synthase F1 subunit gamma, F-ATPase gamma subunit

1 Images
Western blot - Anti-ATP5C1 antibody (AB190875)
  • WB

Supplier Data

Western blot - Anti-ATP5C1 antibody (AB190875)

Primary incubation was 1 hour.

All lanes:

Western blot - Anti-ATP5C1 antibody (ab190875) at 0.1 µg/mL

All lanes:

Rat skeletal muscle lysate (in RIPA buffer) at 35 µg

Predicted band size: 33 kDa

Observed band size: 30 kDa

true

Key facts

Host species

Goat

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Rat

Applications

WB

applications

Immunogen

Synthetic Peptide within Human ATP5F1C aa 1-50. The exact immunogen used to generate this antibody is proprietary information.

P36542

Specificity

ab190875 is expected to recognize both reported isoforms (NP_005165.1; NP_001001973.1). The immunizing peptide represents the N terminus of the mature protein.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.3 µg/mL", "WB-species-notes": "<p>1 hour primary incubation is recommended for this product.</p>" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Cynomolgus monkey": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Orangutan": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab190875 is purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Storage buffer
pH: 7.3 Preservative: 0.02% Sodium azide Constituents: 99% Tris buffered saline, 0.5% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The ATP5C1 protein also known as ATP synthase subunit gamma plays an important role in cellular energy production. This protein has a mass of approximately 55 kDa. It remains primarily expressed in the mitochondria the powerhouse of cells where it forms a part of the ATP synthase complex. ATP5C1 is essential for ATP synthesis a pivotal process for energy production in cells.
Biological function summary

The ATP5C1 protein is an integral component of the F1 sector of the ATP synthase complex. This complex transduces electrochemical energy into ATP which is the main energy carrier in biological systems. ATP5C1 facilitates rotation of the complex’s central stalk enabling energy conversion. It ensures ATP is produced efficiently supporting various cellular processes. ATP5C1 expression levels affect cellular metabolism and energy homeostasis.

Pathways

ATP5C1 holds an important position within oxidative phosphorylation and the mitochondrial electron transport chain. These pathways are vital for ATP production and involve several proteins and enzymes including NADH dehydrogenase cytochrome c oxidase and other ATP synthase subunits. ATP5C1 interacts with these proteins to sustain the flow of electrons coupling it with proton gradients that drive ATP synthesis.

ATP5C1 mutations or malfunctions link to conditions such as mitochondrial diseases and metabolic disorders. For instance alterations in ATP5C1 can affect ATP synthesis efficiency leading to mitochondrial dysfunction. It also associates with neurodegenerative diseases where inefficient energy production exacerbates neuronal degradation. The protein's dysfunction may involve other proteins like ATP5D a fellow subunit within the ATP synthase complex that collaborates in maintaining ATP production.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(1) domain and the central stalk which is part of the complex rotary element. The gamma subunit protrudes into the catalytic domain formed of alpha(3)beta(3). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits.
See full target information ATP5F1C

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 4:775 PubMed34163008

2021

Cyanocobalamin prevents cardiomyopathy in type 1 diabetes by modulating oxidative stress and DNMT-SOCS1/3-IGF-1 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Masao Kakoki,Purushotham V Ramanathan,John R Hagaman,Ruriko Grant,Jennifer C Wilder,Joan M Taylor,J Charles Jennette,Oliver Smithies,Nobuyo Maeda-Smithies
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com